A primary signet ring cell carcinoma of the prostate with bone metastasis with impressive response to FOLFOX and cetuximab

Clin Genitourin Cancer. 2012 Sep;10(3):199-201. doi: 10.1016/j.clgc.2012.01.006. Epub 2012 Mar 10.

Authors

Ana Milena Roldán¹, Natalia Fernández Núñez, Enrique Grande, Augusto Álvarez García, Luis M Antón-Aparicio

Affiliation

¹ Clinical Oncology Department, A Coruña University Hospital, A Coruña, Spain.

PMID: 22409863
DOI: 10.1016/j.clgc.2012.01.006

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antibodies, Monoclonal / administration & dosage
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Bone Neoplasms / diagnostic imaging
Bone Neoplasms / drug therapy
Bone Neoplasms / secondary*
Carcinoma, Signet Ring Cell / diagnostic imaging
Carcinoma, Signet Ring Cell / drug therapy
Carcinoma, Signet Ring Cell / secondary*
Cetuximab
Fluorouracil / administration & dosage
Humans
Leucovorin / administration & dosage
Male
Organoplatinum Compounds / administration & dosage
Oxaliplatin
Prostatic Neoplasms / diagnostic imaging
Prostatic Neoplasms / drug therapy
Prostatic Neoplasms / pathology*
Radiography
Treatment Outcome

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Organoplatinum Compounds
Oxaliplatin
Cetuximab
Leucovorin
Fluorouracil